# N\L Ratio Versus L\A Ratio as a Predictor of Morbidity and Mortality in Sepsis and Septic Shock

> **NCT05825118** · — · UNKNOWN · sponsor: **Tanta University** · enrollment: 50 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DIAGNOSTIC_TEST:** Neutrophil/Lymphocyte ratio and lactate/ albumin ratio will be measured in all patients.

## Key facts

- **NCT ID:** NCT05825118
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05
- **Primary completion:** 2023-09
- **Final completion:** 2023-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05825118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05825118, "N\L Ratio Versus L\A Ratio as a Predictor of Morbidity and Mortality in Sepsis and Septic Shock". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05825118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*